APRIL INABINET: Open Payments
NPI 1528060498 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 23 payments from 13 companies in 2025. Trend: 2023 $746 · 2024 $2,525 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $75 |
| Stryker Corporation | 1 | $58 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| CVRx, Inc. | 2 | $28 |
| Recor Medical Inc | 1 | $25 |
| BETA BIONICS, INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, Wegovy, Kerendia, FLOWTRIEVER CATHETER, S, VERQUVO, DUPIXENT, Barostim Neo System, Paradise Ultrasound Renal Denervation System.
Industry payments across SC — which companies pay providers there.
